Metabolism, tissue distribution and excretion of taxifolin in rat

Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved..

The metabolism, tissue distribution and excretion of taxifolin in rat after oral administration of taxifolin encapsulated zein-caseinate Nanoparticles (TZP) were studied. The isomerization of taxifolin in rat small intestine and colon was found. Besides isomers, 16 metabolites of taxifolin were identified in rat feces, plasma and urine by UPLC-QTOF-MS. In colon, taxifolin underwent the metabolism of hydration, dehydration and ring-fission through the gut microflora. The main metabolites of taxifolin found in plasma and urine were its sulfated, glucuronidated, and/or methylated products. The dynamic variation of taxifolin and its metabolites in tissues and urine were quantified by UPLC-QqQ-MS/MS. Taxifolin and its metabolites could be quickly absorbed and distributed in the tissues, and relatively low concentrations were found in the heart and brain. The feces excretion of taxifolin was determined by HPLC. The total excretion during 24 h was 2.83 ± 0.80% to its given does, and the maximum excretion was found during 8-10 h post administration. Compared with feces, the excretion of taxifolin and its metabolites in urine was much faster, and the total excretion was 1.96 ± 0.23% during 12 h.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:150

Enthalten in:

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 150(2022) vom: 30. Juni, Seite 112959

Sprache:

Englisch

Beteiligte Personen:

Li, Ying [VerfasserIn]
Su, Hang [VerfasserIn]
Yin, Zhong-Ping [VerfasserIn]
Li, Jing-En [VerfasserIn]
Yuan, En [VerfasserIn]
Zhang, Qing-Feng [VerfasserIn]

Links:

Volltext

Themen:

9IKM0I5T1E
9SOB9E3987
Excretion
Journal Article
Metabolism
Quercetin
Taxifolin
Tissue distribution
Zein nanoparticles

Anmerkungen:

Date Completed 03.06.2022

Date Revised 03.06.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.biopha.2022.112959

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM339598328